Outbreak of infection by carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-58 in Belgium
- PMID: 16957031
- PMCID: PMC1698292
- DOI: 10.1128/JCM.00796-06
Outbreak of infection by carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-58 in Belgium
Abstract
Carbapenem-resistant Acinetobacter baumannii isolates were obtained from 17 patients between September 2004 and August 2005 at the Academisch Ziekenhuis Vrije Universiteit Brussel, Brussels, Belgium. These multidrug-resistant isolates, which belonged to a single clone, remained susceptible to colistin and tigecycline only and produced the carbapenem-hydrolyzing oxacillinase OXA-58. This study highlights the importance of the intercountry spread of this beta-lactamase-mediated resistance mechanism and its epidemic evolution.
Figures

References
-
- Brown, S., and S. Amyes. 2006. OXA β-lactamases in Acinetobacter: the story so far. J. Antimicrob. Chemother. 57:1-3. - PubMed
-
- Brown, S., H. K. Young, and S. G. B. Amyes. 2005. Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina. Clin. Microbiol. Infect. 11:11-15. - PubMed
-
- Clark, R. B. 1996. Imipenem resistance among Acinetobacter baumannii: association with reduced expression of a 33-36 kDa outer membrane protein. J. Antimicrob. Chemother. 38:245-251. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources